WPD Pharmaceuticals (TSE:WBIO) has released an update.
WPD Pharmaceuticals has successfully negotiated the settlement of its debt with creditors, who have agreed to accept common shares in exchange for debt forgiveness. Additionally, the company’s former subsidiary, WPD Poland, has restructured into WPD Pharmaceuticals S.A., with the parent company retaining approximately 6% ownership post-restructuring. This move comes alongside an investment in WPD S.A. by ACRX Investments Limited, which has resulted in a slight dilution of WPD’s ownership stake to about 5%.
For further insights into TSE:WBIO stock, check out TipRanks’ Stock Analysis page.
